• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

Depletion of CCN1/CYR61 reduces triple-negative/basal-like breast cancer aggressiveness

9 de March de 2022
Am J Cancer Res. 2022 Feb 15;12(2):839-851. eCollection 2022.ABSTRACTTriple-negative/basal-like…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2022-03-09 11:00:002022-03-09 11:00:00Depletion of CCN1/CYR61 reduces triple-negative/basal-like breast cancer aggressiveness

Facile Synthesis of Unsupported Pd Aerogel for High Performance Formic Acid Microfluidic Fuel Cell

25 de February de 2022
Materials (Basel). 2022 Feb 15;15(4):1422. doi: 10.3390/ma15041422.ABSTRACTIn…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2022-02-25 11:00:002022-02-25 11:00:00Facile Synthesis of Unsupported Pd Aerogel for High Performance Formic Acid Microfluidic Fuel Cell

Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cells

11 de February de 2022
Aging (Albany NY). 2022 Feb 11;14(3):1200-1213. doi: 10.18632/aging.203882.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2022-02-11 11:00:002022-02-11 11:00:00Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cells

Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin

21 de January de 2022
Pharmaceuticals (Basel). 2021 Dec 24;15(1):19. doi: 10.3390/ph15010019.ABSTRACTCOVID-19…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2022-01-21 11:00:002022-01-21 11:00:00Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin

Sensory Features Introduced by Brewery Spent Grain with Impact on Consumers’ Motivations and Emotions for Fibre-Enriched Products

11 de January de 2022
Foods. 2021 Dec 24;11(1):36. doi: 10.3390/foods11010036.ABSTRACTThe…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2022-01-11 11:00:002022-01-11 11:00:00Sensory Features Introduced by Brewery Spent Grain with Impact on Consumers’ Motivations and Emotions for Fibre-Enriched Products

Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells

22 de October de 2021
Cell Death Dis. 2021 Oct 21;12(11):977. doi: 10.1038/s41419-021-04262-x.ABSTRACTInhibitors…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-10-22 10:00:002021-10-22 10:00:00Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells

Whey-Derived Porous Carbon Scaffolds for Bone Tissue Engineering

28 de September de 2021
Biomedicines. 2021 Aug 26;9(9):1091. doi: 10.3390/biomedicines9091091.ABSTRACTPorous…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-09-28 10:00:002021-09-28 10:00:00Whey-Derived Porous Carbon Scaffolds for Bone Tissue Engineering

Ultralight-Weight Graphene Aerogels with Extremely High Electrical Conductivity

12 de September de 2021
Small. 2021 Oct;17(41):e2103407. doi: 10.1002/smll.202103407.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-09-12 10:00:002021-09-12 10:00:00Ultralight-Weight Graphene Aerogels with Extremely High Electrical Conductivity

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer

27 de August de 2021
Cancers (Basel). 2021 Aug 19;13(16):4168. doi: 10.3390/cancers13164168.ABSTRACTThe…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-08-27 10:00:002021-08-27 10:00:00Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer

Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2

27 de August de 2021
Cancers (Basel). 2021 Aug 9;13(16):4009. doi: 10.3390/cancers13164009.ABSTRACTThe…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-08-27 10:00:002021-08-27 10:00:00Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2

Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis

11 de August de 2021
EMBO Mol Med. 2021 Sep 7;13(9):e13929. doi: 10.15252/emmm.202113929.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-08-11 10:00:002021-08-11 10:00:00Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis

Lung Cancer Management with Silibinin: A Historical and Translational Perspective

2 de July de 2021
Pharmaceuticals (Basel). 2021 Jun 11;14(6):559. doi: 10.3390/ph14060559.ABSTRACTThe…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-07-02 10:00:002021-07-02 10:00:00Lung Cancer Management with Silibinin: A Historical and Translational Perspective
Page 4 of 11«‹23456›»

Filter by categories

  • Alemany’s & Piulats’s lab (131)
  • Antolin's lab (36)
  • Aytes's Lab (24)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sureda's & Farre's Lab (259)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}